Kyivstar Acquires Tabletki.ua for $160M, Expanding Digital Healthcare Ecosystem
summarizeSummary
Kyivstar Group acquired Tabletki.ua for $160 million, a strategic move to expand its digital healthcare offerings and leverage synergies within its growing digital ecosystem.
check_boxKey Events
-
Acquisition of Tabletki.ua
Kyivstar Group acquired 100% of Tabletki.ua, a leading Ukrainian online healthcare platform, for approximately $160 million, paid fully in Ukrainian Hryvna.
-
Strategic Expansion
The acquisition is a key step in expanding Kyivstar's digital healthcare ecosystem, complementing existing services like Helsi and Uklon, and aligning with its digital operator strategy.
-
Financial Impact
Tabletki.ua generated LTM EBITDA of $24 million and net profit of $20 million as of September 30, 2025, with the acquisition expected to be immediately earnings accretive.
-
Market Position
Tabletki.ua partners with over 14,000 pharmacies and facilitated 14 million online bookings per month in 2025, with over $1 billion in gross merchandise value.
auto_awesomeAnalysis
Kyivstar Group Ltd. has strategically acquired Tabletki.ua, a leading Ukrainian online healthcare platform, for approximately $160 million. This acquisition, representing a significant portion of Kyivstar's market capitalization, is immediately earnings accretive and aligns with the company's strategy to expand its digital services portfolio. The integration of Tabletki.ua, which facilitated over $1 billion in gross merchandise value in 2025, is expected to create substantial synergies with Kyivstar's existing digital health platform, Helsi, and other services, further boosting user engagement and strengthening its position in the Ukrainian digital ecosystem. This move follows a period of capital raising and financial adjustments, indicating a strategic deployment of resources for growth.
At the time of this filing, KYIV was trading at $12.12 on NASDAQ in the Technology sector, with a market capitalization of approximately $2.8B. The 52-week trading range was $10.16 to $16.48. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.